相关实验视频

Updated: Jan 7, 2026

Protocol for Relative Hydrodynamic Assessment of Tri-leaflet Polymer Valves

Protocol for Relative Hydrodynamic Assessment of Tri-leaflet Polymer Valves

Published on: October 17, 2013

在血液透析患者中的机械与生物假体心脏门

Sun Kyun Ro¹, Jiyeong Kim², Soorack Ryu²

¹Department of Thoracic and Cardiovascular Surgery, Hanyang University Guri Hospital, Hanyang University College of Medicine, Seoul, Korea.

The Journal of thoracic and cardiovascular surgery

|December 26, 2025

概括

对于需要更换门的血液透析患者来说,生物假体门的生存率与机械门相当. 年轻的患者可能会从生物假体门中受益,考虑到它们的耐用性和出血风险.

科学领域:

心血管外科心血管外科
腎臟病學 (nephrology) 是一種醫學專業.
生物医学工程生物医学工程

背景情况:

血液透析患者的门置换是复杂的,因为预期寿命缩短和生物假体门退化.
在生物假肢 (BP) 和机械门 (MP) 之间做出选择,需要在这个独特的人群中平衡风险和收益.

研究的目的:

在血液透析患者中,比较BP和MP之间的临床结果,预期寿命和门耐用性.
为改善患者管理提供假体门选择的信息.

主要方法:

来自韩国国家医疗保险共享服务数据库的765名血液透析患者的回顾性分析.
在BP (N=421) 和MP (N=344) 组之间的早期和晚期临床结果的比较.
年龄依赖子组分析和晚期事件的竞争性风险分析.

主要成果:

在调整后,BP和MP组的早期结果和晚期死亡率在BP和MP组之间相似.
高血压组有更高的重复大动脉替换率;MP组有更多的胃肠道出血.
估计的中位生存时间因年龄而异:6.6年 (<50),4.0年 (50-64) 和2.1年 (≥65).
使用MP与较低的门耐用性事件有关,但较高的重大出血事件.

结论:

生物假体门可能是年轻血液透析患者需要更换门的合适选择.
在为年轻患者选择门时,考虑高血症和脏移植候选人是很重要的.
门的选择需要仔细考虑患者的年龄,并发病症和所需的耐用性与出血风险.

关键词:

血液透析是血液透析的方法之一.预期寿命预期寿命门的更换门的更换门的选择门的选择

更多相关视频

Author Spotlight: Advancing Cardiac Procedure Testing Prior to Embarking on Large Animal Studies

Author Spotlight: Advancing Cardiac Procedure Testing Prior to Embarking on Large Animal Studies

Published on: August 25, 2023

Transplantation of Pulmonary Valve Using a Mouse Model of Heterotopic Heart Transplantation

Transplantation of Pulmonary Valve Using a Mouse Model of Heterotopic Heart Transplantation

Published on: July 23, 2014

相关概念视频

Hemodialysis I: Introduction

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...

Hemodialysis II: Procedure and Complications

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...

Hemodialysis III: Nursing Management

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...